ribociclib and Hemolysis

ribociclib has been researched along with Hemolysis* in 1 studies

Other Studies

1 other study(ies) available for ribociclib and Hemolysis

Article	Year
Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising Journal of drug targeting, 2022, Volume: 30, Issue:10 The current research investigated the development and evaluation of dual drug-loaded nanostructure lipidic carriers (NLCs) of green tea extract and Ribociclib.. The prominent potential of green tea extract and RBO-loaded NLCs in enhancing their therapeutic efficacy for better treatment of breast cancer. Topics: Animals; Antioxidants; Drug Carriers; Excipients; Female; Hemolysis; Lipids; Nanostructures; Neoplasms; Particle Size; Rats; Rats, Wistar; Tea	2022

Article

Year

Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising

Journal of drug targeting, 2022, Volume: 30, Issue:10

The current research investigated the development and evaluation of dual drug-loaded nanostructure lipidic carriers (NLCs) of green tea extract and Ribociclib.. The prominent potential of green tea extract and RBO-loaded NLCs in enhancing their therapeutic efficacy for better treatment of breast cancer.

Topics: Animals; Antioxidants; Drug Carriers; Excipients; Female; Hemolysis; Lipids; Nanostructures; Neoplasms; Particle Size; Rats; Rats, Wistar; Tea

2022